REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 68 filers reported holding REVANCE THERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 1.9%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 4,415,689 | $86,106,000 | 6.66% |
| Evolutionary Tree Capital Management, LLC | 176,336 | $3,439,000 | 2.39% |
| Essex Woodlands Management, Inc. | 457,085 | $8,913,000 | 2.16% |
| HealthCor Management, L.P. | 1,423,425 | $27,757,000 | 1.85% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,112,325 | $21,690,000 | 0.86% |
| Waypoint Capital Advisors, LLC | 53,989 | $1,016,000 | 0.60% |
| Antara Capital LP | 679,600 | $13,252,000 | 0.40% |
| Rhenman & Partners Asset Management AB | 198,358 | $3,868,000 | 0.38% |
| Walleye Capital LLC | 505,701 | $9,861,000 | 0.26% |
| Polar Capital Holdings Plc | 2,456,497 | $47,902,000 | 0.22% |